Published in Neuroscience on January 01, 2004
Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell (2008) 1.79
Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell (2005) 1.33
Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS. Neuron Glia Biol (2006) 1.32
Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data. Mol Cancer Ther (2008) 1.20
Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res (2010) 1.08
Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors. PLoS One (2011) 1.02
Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. Stem Cells (2009) 1.01
Gene expression changes after seizure preconditioning in the three major hippocampal cell layers. Neurobiol Dis (2007) 0.93
Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell (2006) 0.90
Proteomics analyses of human optic nerve head astrocytes following biomechanical strain. Mol Cell Proteomics (2011) 0.88
Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury. Mol Cell Proteomics (2016) 0.87
Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice. Mol Ther Nucleic Acids (2016) 0.84
Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. J Cell Physiol (2012) 0.83
Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha. Mol Biol Cell (2009) 0.81
Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities. BMC Neurosci (2009) 0.79
Estradiol attenuates down-regulation of PEA-15 and its two phosphorylated forms in ischemic brain injury. Lab Anim Res (2015) 0.77
Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther (2014) 0.76
Vitamin D3 signalling in the brain enhances the function of phosphoprotein enriched in astrocytes--15 kD (PEA-15). J Cell Mol Med (2009) 0.76
Hyperglycemia aggravates decreases of PEA-15 and its two phosphorylated forms in cerebral ischemia. J Vet Med Sci (2017) 0.75
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities. Pharmaceuticals (Basel) (2015) 0.75
Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice. Sci Rep (2016) 0.75
PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell (2001) 2.73
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst (1994) 2.58
Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science (1999) 2.17
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
A third locus for autosomal dominant cerebellar ataxia type I maps to chromosome 14q24.3-qter: evidence for the existence of a fourth locus. Am J Hum Genet (1994) 1.76
Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med (1995) 1.62
The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res (2001) 1.59
Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci (2001) 1.58
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ (2011) 1.44
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43
A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain. J Lipid Mediat (1992) 1.41
Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci (1998) 1.37
M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem (1992) 1.31
Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol (1997) 1.31
FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology (2010) 1.25
Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J Neuroradiol (2001) 1.24
TTF-1, a homeodomain gene required for diencephalic morphogenesis, is postnatally expressed in the neuroendocrine brain in a developmentally regulated and cell-specific fashion. Mol Cell Neurosci (2001) 1.24
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet (1997) 1.24
Intracellular substrates for extracellular signaling. Characterization of a ubiquitous, neuron-enriched phosphoprotein (stathmin). J Biol Chem (1989) 1.23
Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell (2000) 1.22
An outbreak of Ochrobactrum anthropi bacteraemia in five organ transplant patients. J Hosp Infect (1994) 1.16
Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. Ann Neurol (1995) 1.16
Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J Neurosci (1995) 1.16
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet (1995) 1.15
Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene (2006) 1.14
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem (1998) 1.13
Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells? J Cell Biochem (1990) 1.12
Dysembryoplastic neuroepithelial tumors: nonspecific histological forms -- a study of 40 cases. J Neurooncol (1999) 1.12
Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem (1995) 1.10
[Gliomas: WHO and Sainte-Anne Hospital classifications]. Ann Pathol (2000) 1.08
Identification of residues essential for human paraoxonase (PON1) arylesterase/organophosphatase activities. Biochemistry (1999) 1.06
Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer. Prostate Cancer Prostatic Dis (2011) 1.04
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene (2007) 1.03
Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog Brain Res (1998) 1.02
Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem (2000) 1.02
Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor. Neuroscience (1995) 1.02
A role for transforming growth factor alpha as an inducer of astrogliosis. J Neurosci (1998) 1.01
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo. Neurosci Lett (1992) 1.00
Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol (1997) 1.00
Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess. Diagn Interv Imaging (2012) 0.99
IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ (2010) 0.98
Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J Neurosci (1998) 0.97
[Adolescent pregnancy]. Rev Obstet Ginecol Venez (1970) 0.97
Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria? Eur J Radiol (2011) 0.97
Transforming growth factor-alpha gene expression in the hypothalamus is developmentally regulated and linked to sexual maturation. Neuron (1992) 0.96
The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem (1996) 0.96
The Establishment of the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS): A Pilot Project on Poultry Farms, Slaughterhouses and Retail Market. Zoonoses Public Health (2015) 0.96
Expression of epidermal growth factor receptor changes in the hypothalamus during the onset of female puberty. Mol Cell Neurosci (1994) 0.95
[Möbius syndrome: ocular and clinical manifestations]. J Fr Ophtalmol (2007) 0.94
The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2. Am J Hum Genet (1995) 0.94
Solid mesenchymal hamartoma in an adult: a case report. J Clin Pathol (2006) 0.93
Liposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal. Free Radic Biol Med (2000) 0.92
Pressure-induced molten globule state of cholinesterase. FEBS Lett (1995) 0.92
Differential regulation of NGF receptors in primary sensory neurons by adjuvant-induced arthritis in the rat. Pain (2001) 0.91
The influence of solvent composition on global dynamics of human butyrylcholinesterase powders: a neutron-scattering study. Biophys J (2004) 0.91
Genetic heterogeneity of autosomal dominant cerebellar ataxia type 1: clinical and genetic analysis of 10 French families. Neurology (1993) 0.90
[Ureteral metastasis of prostatic adenocarcinoma. Review of the literature]. Arch Esp Urol (1989) 0.90
Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur J Pharmacol (1995) 0.89
The role of arachidonic acid and its metabolites in the release of neuropeptides. Ann N Y Acad Sci (1989) 0.89
Direct phasing at low resolution of a protein copurified with human paraoxonase (PON1). Acta Crystallogr D Biol Crystallogr (2003) 0.89
Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. J Neurochem (1997) 0.88
Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. Brain (1993) 0.87
Two temporal stages of oligodendroglial response to excitotoxic lesion in the gray matter of the adult rat brain. Exp Neurol (2001) 0.87
An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX. Toxicology (2008) 0.86
Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis (2013) 0.86
Stabilization of the active form(s) of human paraoxonase by human phosphate-binding protein. Biochem Soc Trans (2007) 0.86
Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom. Neurochem Int (1983) 0.86
[Electromyographic study of 50 cases of Werdnig-Hoffmann disease]. Rev Electroencephalogr Neurophysiol Clin (1983) 0.85
Is DRPLA also linked to 14q? Nat Genet (1994) 0.85
Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmatic benzodiazepine pharmacokinetics. Arch Toxicol (2000) 0.84
Transforming growth factor alpha: a promoter of motoneuron survival of potential biological relevance. J Neurosci (2001) 0.84
[Severe cholestatic hepatitis revealing a DRESS syndrome]. Rev Med Interne (2013) 0.84
Purification, molecular characterization and catalytic properties of a Pseudomonas fluorescens enzyme having cholinesterase-like activity. Biochim Biophys Acta (1998) 0.84
Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas. Brain Res Mol Brain Res (2005) 0.83
Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes. Oncogene (2006) 0.83
Effect of DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and sensitivity to drugs acting on adrenergic receptors in the rat. Sleep (1988) 0.83
Diabetes knowledge and its determinants in a Mexican population. Diabetes Educ (1999) 0.83
Stereotactic CT-guided brain biopsy in the dog. J Small Anim Pract (2002) 0.83
Modulation by monoamines of somatostatin-sensitive adenylate cyclase on neuronal and glial cells from the mouse brain in primary cultures. J Neurochem (1985) 0.83
[Criteria of diagnosis and grading of oligodendrogliomas or oligo-astrocytomas according to the WHO and Sainte-Anne classifications]. Neurochirurgie (2005) 0.82
[Acute pseudotumoral demyelination with regressive attacks]. Arch Fr Pediatr (1983) 0.82
SCA2 is not a major locus for ADCA type I in French families. Am J Med Genet (1995) 0.82
Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate. J Neurochem (1990) 0.82
Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyte monolayers. Neurosci Lett (1997) 0.82
Transcranial Doppler sonography in fulminant hepatic failure. Transplant Proc (2003) 0.82
Stathmin phosphorylation patterns discriminate between distinct transduction pathways of human T lymphocyte activation through CD2 triggering. FEBS Lett (1991) 0.81
Two simian virus 40 (SV40)-transformed cell lines from the mouse striatum and mesencephalon presenting astrocytic characters. I. Immunological and pharmacological properties. Brain Res (1986) 0.81
[Cerebral cavernomas, epilepsy and seizures. Natural history and therapeutic strategy]. Neurochirurgie (2005) 0.81
Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival. Neuropathol Appl Neurobiol (2000) 0.81
Genetic heterogeneity of autosomal dominant cerebellar ataxia type I: evidence for the existence of a third locus. Hum Mol Genet (1993) 0.81
Keeping TNF-induced apoptosis under control in astrocytes: PEA-15 as a 'double key' on caspase-dependent and MAP-kinase-dependent pathways. Prog Brain Res (2001) 0.81